Business Wire

Masimo Announces FDA Clearance of Pediatric Indication for SedLine ® Brain Function Monitoring and the SedLine Pediatric EEG Sensor

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the FDA clearance of SedLine ® brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG ...
Yahoo Finance

Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. SedLine helps clinicians monitor ...
Nasdaq

Masimo : FDA Oks Pediatric Indication For SedLine Brain Function Monitoring And EEG Sensor

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
Nasdaq

Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®

Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the ...